- $2.45m
- $6.34m
- $11.42m
Brief: NEXGEL Announces Spin-Off Of Drug Delivery Program Into NexGelRx
Nexgel Inc reports results for the quarter ended June 30 - Earnings Summary
Nexgel Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: NEXGEL Appoints Steve Ciardiello to its Board of Directors
Brief: Nexgel Announces $950,000 Registered Direct Offering And Concurrent Private Placement
Nexgel Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Nexgel Appoints Joseph Mcguire As Chief Financial Officer
Brief: Nexgel Preannounces Expected Record Third Quarter 2024 Revenue Of $2.85 Million
Nexgel rises on better-than-expected Q3 revenue
Brief: Nexgel Subsidiary, CG Converting And Packaging, Announces It Will Supply Silverseal To Cintas Corporation
Brief: Nexgel And STADA Partner To Launch Leading European DAO Enzyme Supplement, Histasolv, In North America
Brief: NEXGEL Acquires International Beauty Brand, Silly George
Brief: Nexgel Subsidiary, Cg Converting And Packaging, Begins 12,000 Square Foot Expansion Of Texas Facility
Brief: Nexgel Acquires Kenkoderm Psoriasis Skincare Line
Brief: Nexgel Secures Supply Agreement With Abbvie
Brief: NEXGEL Q2 revenue USD 1.167 million
Brief: NEXGEL Reports First Quarter 2023 Financial Results
U.S. STOCKS ON THE MOVE-CalciMedica, Natgas firms,
U.S. STOCKS ON THE MOVE-ReNew Energy, First Horizon, Block Inc